Flow cytometric methods for detection and quantification of apoptosis.
Steensma
David P
DP
Division of Hematology, Department of Internal Medicine, Mayo Clinic, Mayo Foundation, Rochester, MN, USA.
Timm
Michael
M
Witzig
Thomas E
TE
D000818:Animals; D017304:Annexin A5 / Q000032:analysis; D017209:Apoptosis / Q000187:drug effects; D002462:Cell Membrane / Q000648:ultrastructure; D002463:Cell Membrane Permeability; D003546:Cysteine Endopeptidases / Q000378:metabolism; D004249:DNA Damage; D053938:DNA Fragmentation; D004273:DNA, Neoplasm / Q000032:analysis; D003609:Dactinomycin / Q000031:analogs & derivatives* / Q000032:analysis / Q000378:metabolism; D004789:Enzyme Activation; D005434:Flow Cytometry / Q000379:methods*; D005456:Fluorescent Dyes / Q000032:analysis / Q000378:metabolism; D006801:Humans; D020287:In Situ Nick-End Labeling; D009369:Neoplasms / Q000473:pathology; D009391:Nephelometry and Turbidimetry; D009691:Nucleic Acid Denaturation
D017304:Annexin A5; D004273:DNA, Neoplasm; D005456:Fluorescent Dyes; D003609:Dactinomycin; C025942:7-aminoactinomycin D; D003546:Cysteine Endopeptidases